Canopus BioPharma Incorporated
Canopus BioPharma Incorporated (CBIA) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001404356 · CBIA · OTC · as of Jun 10, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001404356 · Updated hourly · Not investment advice
Latest Key Filings
No recent filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Canopus BioPharma Incorporated (OTC: CBIA) has submitted 19 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1999. As a Financial Services sector company with CIK 0001404356, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Canopus BioPharma Incorporated's most comprehensive regulatory disclosure. The most recent Canopus BioPharma Incorporated 10-K was filed on — for fiscal year ending —. Historical CBIA 10-K annual reports are available from 2007 through —.
Investors researching Canopus BioPharma Incorporated SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
CBIA SEC Filings · 8 questionsCanopus BioPharma Incorporated (CBIA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 19 filings and access original documents at no cost. Canopus BioPharma Incorporated's CIK is 0001404356.